NCT07106203

Brief Summary

This study aims to evaluate the effects of Pursed-Lip Breathing (PLB) exercises on physiological parameters (such as respiratory rate, heart rate, and oxygen saturation) and discharge readiness in children diagnosed with pneumonia. The study is designed as a randomized controlled trial involving pediatric patients between the ages of 3 and 4. The intervention includes guided PLB exercises performed twice daily for three consecutive days. Data will be collected before and after each session to assess changes in physiological measures and readiness for hospital discharge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 6, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

October 6, 2025

Status Verified

October 1, 2025

Enrollment Period

3 months

First QC Date

July 9, 2025

Last Update Submit

October 1, 2025

Conditions

Keywords

Pursed-Lip BreathingPediatric PneumoniaRespiratory FunctionDischarge ReadinessPhysiological ParametersPulmonary RehabilitationNon-pharmacological intervention

Outcome Measures

Primary Outcomes (3)

  • Change in Respiratory Rate

    Respiratory rate will be measured before and after each PLB session to evaluate the intervention's effect on pulmonary function.

    Before and after each PLB session over a 3-day intervention period

  • Change in Heart Rate

    Heart rate will be recorded before and after each PLB session to assess changes in cardiovascular response.

    Before and after each PLB session over a 3-day intervention period

  • Change in Oxygen Saturation (SpO₂)

    Peripheral oxygen saturation (SpO₂) will be evaluated before and after each PLB session to determine its impact on oxygenation.

    Before and after each PLB session over a 3-day intervention period

Secondary Outcomes (1)

  • Change in Pediatric Readiness for Hospital Discharge Scale - Parent Form (Ped-RHDS) Scores

    Day 1 (morning) and Day 3 (evening)

Study Arms (2)

Control Group

NO INTERVENTION

Children aged 3-4 years diagnosed with pneumonia will receive only standard hospital care. No additional respiratory exercise will be applied. Physiological parameters will be measured at the same intervals as the intervention group for comparison.

PLB Intervention Group

EXPERIMENTAL

Children aged 3-4 years diagnosed with pneumonia will receive Pursed-Lip Breathing (PLB) exercises under nurse supervision, twice daily for three consecutive days. PLB will be performed using playful methods with a toy (e.g., saxophone ball). Respiratory rate, heart rate, and oxygen saturation will be measured before and after each session.

Behavioral: Pursed-Lip Breathing (PLB)

Interventions

Children in the intervention group will receive Pursed-Lip Breathing exercises twice daily for three days under nurse supervision. Exercises will be applied using playful techniques with a toy (e.g., saxophone ball). Physiological parameters will be measured before and after each session.

PLB Intervention Group

Eligibility Criteria

Age3 Years - 4 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 3 to 4 years
  • Diagnosed with community-acquired pneumonia (CAP), defined as pneumonia occurring in a previously healthy child within 14 days of symptom onset and requiring hospitalization
  • The child's primary caregiver is the mother
  • Both mother and child must remain in the hospital for at least 3 days
  • Hospitalization due to pneumonia with an expected average stay of 4-5 days, based on disease severity and clinical condition
  • Mother must be present as a caregiver throughout the hospital stay
  • Voluntary participation with signed informed consent from the parent or legal guardian

You may not qualify if:

  • Presence of any chronic disease in addition to pneumonia
  • Mother not staying as a caregiver during hospitalization
  • Withdrawal of consent by the mother and/or child
  • Discharge before 3 days for any reason (e.g., refusal of treatment, early discharge request)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University Health Sciences Institute and Research Hospital - Department of Pediatrics

Erzurum, Erzurum, 25070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PneumoniaRespiratory Aspiration

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Türkan KADIROĞLU, Asst Prof

    Ataturk University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Türkan KADİROĞLU, Asst Prof

CONTACT

Emrah DURSUN, Res Asst

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to participant group assignments to minimize detection bias. Data analysis will also be conducted by an independent researcher who is unaware of group allocations. Due to the nature of the intervention, participants and intervention providers cannot be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This randomized controlled study includes two arms: an intervention group receiving Pursed-Lip Breathing (PLB) exercises twice daily and a control group receiving standard care. The intervention will be performed over a 3-day period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 9, 2025

First Posted

August 6, 2025

Study Start

November 1, 2025

Primary Completion

February 1, 2026

Study Completion

May 1, 2026

Last Updated

October 6, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) that underlie the results reported in this study (after de-identification) will be shared with qualified researchers. Data will be available for secondary analysis upon request, starting 6 months after publication and for a period of 2 years.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 6 months after publication and ending 2 years later.
Access Criteria
With researchers who submit a methodologically sound proposal and receive approval from the study team.
More information

Locations